Загрузка...
Targeting the Microenvironment in MDS: The Final Frontier
Myelodysplastic syndromes (MDS) are a heterogeneous group of malignant disorders of hematopoietic stem and progenitor cells (HSPC), mainly characterized by ineffective hematopoiesis leading to peripheral cytopenias and progressive bone marrow failure. While clonal dominance is nearly universal at di...
Сохранить в:
| Опубликовано в: : | Front Pharmacol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364152/ https://ncbi.nlm.nih.gov/pubmed/32742264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01044 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|